Back

Plasma galectin-3 as a novel biomarker to cardiac events in very high-risk atherosclerotic cardiovascular disease population: a prospective study in an upper-middle-income country

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Poster session 3 - Understanding cardiovascular risk development: novel mechanisms (2) Epidemiology, Prognosis, Outcome Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mr Faqrizal Ria Qhabibi

West Jakarta (Indonesia)

6 More presentations in this session

Presentation thumbnail
Discussants - Understanding cardiovascular risk development: novel mechanisms (2)
Presentation thumbnail
Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction
Doctor D. Delialis (Athens, GR)
Abstract Slides
Presentation thumbnail
Effect of metabolic syndrome on mean platelet volume and relationship to extent of coronary artery disease.
Doctor E. Sdogkos (Veria, GR)
Abstract Slides
Presentation thumbnail
Unlocking the mystery. Exploring the relationship between PFO anatomical features and the right to left shunt size
Doctor D. Maritsa (London, GB)
Abstract
Presentation thumbnail
Red cell distribution width - prognostic parameter that could be used in heart failure patients
Doctor A. Catana (Bucharest, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Understanding cardiovascular risk development: novel mechanisms (2)

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources